Drug profile · INN
teprotumumab-trbw
TEPEZZA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
teprotumumab-trbw (TEPEZZA) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN teprotumumab-trbw
Brand TEPEZZA
Route INJECTION
Formulation INJECTABLE
Frequently asked questions
What is teprotumumab-trbw?
teprotumumab-trbw (TEPEZZA) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for teprotumumab-trbw?
TEPEZZA is a marketed brand name for teprotumumab-trbw. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of teprotumumab-trbw?
teprotumumab-trbw has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.